HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75 | +87.5% | 1,967 | +77.2% | 0.00% | – |
| Q2 2023 | $40 | +25.0% | 1,110 | +30.9% | 0.00% | – |
| Q1 2023 | $32 | +45.5% | 848 | +123.2% | 0.00% | – |
| Q4 2022 | $22 | -99.8% | 380 | +59.7% | 0.00% | – |
| Q3 2022 | $9,000 | +350.0% | 238 | +495.0% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 40 | +150.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 16 | -80.5% | 0.00% | – |
| Q4 2021 | $3,000 | +200.0% | 82 | +203.7% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 27 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $51,293,000 | 7.24% |
| First Light Asset Management, LLC | 2,050,273 | $93,103,000 | 5.59% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,350,870 | $61,343,000 | 5.06% |
| SNYDER CAPITAL MANAGEMENT L P | 3,176,404 | $144,241,000 | 4.04% |
| DOHENY ASSET MANAGEMENT /CA | 91,930 | $4,175,000 | 2.69% |
| Redwood Investments, LLC | 538,656 | $24,460,000 | 1.97% |
| HighMark Wealth Management LLC | 53,457 | $2,427,000 | 1.78% |
| Taylor Wealth Management Partners | 85,409 | $3,878,000 | 1.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 66,673 | $3,028,000 | 1.35% |
| Granite Investment Partners, LLC | 919,029 | $41,733,000 | 1.29% |